Literature DB >> 27933671

Causal inference in obesity research.

P W Franks1,2,3, N Atabaki-Pasdar1.   

Abstract

Obesity is a risk factor for a plethora of severe morbidities and premature death. Most supporting evidence comes from observational studies that are prone to chance, bias and confounding. Even data on the protective effects of weight loss from randomized controlled trials will be susceptible to confounding and bias if treatment assignment cannot be masked, which is usually the case with lifestyle and surgical interventions. Thus, whilst obesity is widely considered the major modifiable risk factor for many chronic diseases, its causes and consequences are often difficult to determine. Addressing this is important, as the prevention and treatment of any disease requires that interventions focus on causal risk factors. Disease prediction, although not dependent on knowing the causes, is nevertheless enhanced by such knowledge. Here, we provide an overview of some of the barriers to causal inference in obesity research and discuss analytical approaches, such as Mendelian randomization, that can help to overcome these obstacles. In a systematic review of the literature in this field, we found: (i) probable causal relationships between adiposity and bone health/disease, cancers (colorectal, lung and kidney cancers), cardiometabolic traits (blood pressure, fasting insulin, inflammatory markers and lipids), uric acid concentrations, coronary heart disease and venous thrombosis (in the presence of pulmonary embolism), (ii) possible causal relationships between adiposity and gray matter volume, depression and common mental disorders, oesophageal cancer, macroalbuminuria, end-stage renal disease, diabetic kidney disease, nuclear cataract and gall stone disease, and (iii) no evidence for causal relationships between adiposity and Alzheimer's disease, pancreatic cancer, venous thrombosis (in the absence of pulmonary embolism), liver function and periodontitis.
© 2016 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  Bayesian network analysis; Mendelian randomization; adiposity; genetics; lifestyle

Mesh:

Year:  2016        PMID: 27933671     DOI: 10.1111/joim.12577

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  Relationships between Sexual Orientation, Weight, and Health in a Population-Based Sample of California Women.

Authors:  Michele J Eliason; Emma V Sanchez-Vaznaugh; David Stupplebeen
Journal:  Womens Health Issues       Date:  2017-05-24

2.  Associations between adipose tissue volume and small molecules in plasma and urine among asymptomatic subjects from the general population.

Authors:  Lerina Otto; Kathrin Budde; Gabi Kastenmüller; Anne Kaul; Uwe Völker; Henry Völzke; Jerzy Adamski; Jens P Kühn; Jan Krumsiek; Anna Artati; Matthias Nauck; Nele Friedrich; Maik Pietzner
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

3.  Circulating Metabolites Associated with Body Fat and Lean Mass in Adults with Overweight/Obesity.

Authors:  Christopher Papandreou; Jesús García-Gavilán; Lucía Camacho-Barcia; Thea T Hansen; Anders Sjödin; Joanne A Harrold; Jason C G Halford; Mònica Bulló
Journal:  Metabolites       Date:  2021-05-13

Review 4.  Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative.

Authors:  Maria de Fátima Brito; Carla Torre; Beatriz Silva-Lima
Journal:  Front Med (Lausanne)       Date:  2021-07-06

5.  Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity.

Authors:  Linsha Ma; Liang Hu; Luyuan Jin; Jiangyi Wang; Xiangchun Li; Weili Wang; Shimin Chang; Chunmei Zhang; Jingsong Wang; Songlin Wang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-08

6.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.